Smith & Nephew is trading at £1021.00 (-4.04%) as healthcare stocks fall broadly.
- The XLV healthcare ETF is down 2.19% amid worsening insurance-coverage concerns, while broader risk aversion adds pressure.
- No clear company-specific catalyst directly explains the September 8 decline. The $250 million bond tender offer concerns debt-portfolio management, not an adverse operating development.
- Recent weak orthopaedic demand and guidance concerns remain background sentiment factors.